Technocracy
Member
Stem Cell Review -current perspectives
Courtesy of ISSCR's newsletter (The Pulse), the Stem Cell Review (1) is a 10-part series,via videos, that focus on the state of stem cell science today, including medical applications and the business of stem cells. The videos can be accessed through the ISSCR website.
The latest episode (aired Oct 29 09) of Stem Cell Review is entitled: Looking Forward to 2015 and features experts' perspectives on where they see stem cell science going in the next five years.
See also a website video presenting an Overview of Harvard Stem Cell Institute - First 5 years Harvard Stem Cell Institute's overall aim is to use the power of stem cell biology to understand and ultimately treat selected diseases and conditions. Achieving this will require advances on many levels, from basic biology to patient delivery systems.
http://www.isscr.org/index.htmhttp://www.isscr.org/newsletter/index.cfm?fuseaction=Newsletter.showThisIssue&Issue_ID=98http://biobusiness.tv/videos/210
The Stem Cell Review is a BioBusiness.TV Original Production presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.
http://www.nyhealth.gov/press/releases/2009/2009-11-03_nystem_research_initiative.htm
http://nystem.com/events_full_board_meetings.html
http://www.hsci.harvard.edu/harvard-stem-cell-institute-first-5-years
Courtesy of ISSCR's newsletter (The Pulse), the Stem Cell Review (1) is a 10-part series,via videos, that focus on the state of stem cell science today, including medical applications and the business of stem cells. The videos can be accessed through the ISSCR website.
The latest episode (aired Oct 29 09) of Stem Cell Review is entitled: Looking Forward to 2015 and features experts' perspectives on where they see stem cell science going in the next five years.
-How will stem cells change the way we think about treating diseases? .
-What are the diseases we'll be treating, and the tools we'll be using in 2015?
-Where will we be in terms of clinical trials?
-What are the dangers in the stem cell hype, and medical tourism?
-How will stem cells pave the way for personalized medicine, and more rational treatments?
-How important will stem cells become in the drug discovery process? Discussed in the episode are the eye (macular degeneration), the skin, diabetes (type 1 & 2), blood and autoimmune diseases, glioblastoma, HIV, and more.
Since the beginning of 2008, New York State has allocated more than $165 million through the Empire State Stem Cell Board to support promising stem cell scientists in the development of new research, training, collaboration and infrastructure. Governor Paterson has led the effort to commit $600 million over the next decade to advance stem cell science in New York State as part of a New Economy based on knowledge, technology and innovation. (2) -What are the diseases we'll be treating, and the tools we'll be using in 2015?
-Where will we be in terms of clinical trials?
-What are the dangers in the stem cell hype, and medical tourism?
-How will stem cells pave the way for personalized medicine, and more rational treatments?
-How important will stem cells become in the drug discovery process? Discussed in the episode are the eye (macular degeneration), the skin, diabetes (type 1 & 2), blood and autoimmune diseases, glioblastoma, HIV, and more.
No area of science better exemplifies New York's New Economy than does stem cell research and its potential for creating meaningful, high-paying jobs while exploring potential therapies for some of the most devastating diseases.
NYSTEM's next Board meeting is scheduled for Dec. 11, 209, Friday.
See also a website video presenting an Overview of Harvard Stem Cell Institute - First 5 years Harvard Stem Cell Institute's overall aim is to use the power of stem cell biology to understand and ultimately treat selected diseases and conditions. Achieving this will require advances on many levels, from basic biology to patient delivery systems.
http://www.isscr.org/index.htmhttp://www.isscr.org/newsletter/index.cfm?fuseaction=Newsletter.showThisIssue&Issue_ID=98http://biobusiness.tv/videos/210
The Stem Cell Review is a BioBusiness.TV Original Production presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.
http://www.nyhealth.gov/press/releases/2009/2009-11-03_nystem_research_initiative.htm
http://nystem.com/events_full_board_meetings.html
http://www.hsci.harvard.edu/harvard-stem-cell-institute-first-5-years